Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel Test
Short Name: Arthrogryposis & CMS Gene Panel
Also known as: AMC-CMS Panel, Arthrogryposis and CMS Genetic Test
Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel Test test available at DNA Labs India for ₹36,000. Uses Next-Generation Sequencing (NGS), Sanger sequencing for variant confirmation on Amniotic fluid/ Chorionic villi/ Peripheral blood samples. Results in Reports are typically available within 4-6 weeks after sample receipt.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last reviewed: September 7, 2026
Overview
The purpose of this gene panel is to identify the underlying genetic cause in individuals suspected of having Arthrogryposis Multiplex Congenita or Congenital Myasthenic Syndrome. By detecting pathogenic variants in genes associated with these conditions, the test aids in confirming the diagnosis, differentiating between subtypes, guiding treatment decisions, and providing accurate recurrence risk for family planning. It is also valuable for prenatal diagnosis in at-risk pregnancies.
- Test Code
- 6037
- CPT Code
- 81408
- ICD Code
- Q74.3 (Arthrogryposis), G70.9 (CMS)
- Price
- ₹36,000
- Sample Type
- Amniotic fluid/ Chorionic villi/ Peripheral blood
- Result Time
- Reports are typically available within 4-6 weeks after sample receipt.
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS), Sanger sequencing for variant confirmation
Sample Collection
No special preparation is required. For prenatal samples, the procedure will be performed by a specialist. Please bring a doctor's prescription.
Method: Venipuncture or amniocentesis/CVS by specialist
Laboratory Analysis
Blood sample: standard venipuncture. Amniotic fluid/CVS: performed by an obstetrician under ultrasound guidance.
Report Delivery
No specific precautions. Resume normal activities.
Timeline: Reports are typically available within 4-6 weeks after sample receipt.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this gene panel is to identify the underlying genetic cause in individuals suspected of having Arthrogryposis Multiplex Congenita or Congenital Myasthenic Syndrome. By detecting pathogenic variants in genes associated with these conditions, the test aids in confirming the diagnosis, differentiating between subtypes, guiding treatment decisions, and providing accurate recurrence risk for family planning. It is also valuable for prenatal diagnosis in at-risk pregnancies.
How to Prepare
- Peripheral blood: Collect in EDTA vacutainer, mix gently.
- Amniotic fluid: Collect in sterile container, avoid contamination.
- Chorionic villi: Collect in sterile container with transport medium.
- Transport samples at 2-8°C if delivery within 24 hours, otherwise frozen.
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"Genetic testing for arthrogryposis and CMS is crucial for accurate diagnosis, prognosis, and recurrence risk counseling. Early identification can guide management and family planning."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolyzed blood sample
- Clotted blood sample
- Incorrect container
- Sample not labeled properly
- Sample received after prolonged transit without proper temperature
Understanding Your Results
Confirms the genetic diagnosis. Genetic counseling recommended for family planning.
Likely causative; further testing may be needed for confirmation.
Insufficient evidence to determine pathogenicity. Additional family studies may help.
Does not rule out genetic cause; other genes or non-genetic etiologies may be considered.
Consult a geneticist or neurologist if you or your child have symptoms suggestive of arthrogryposis or CMS, or if you have a family history of these conditions. Genetic counseling is recommended before and after testing.
Limitations
- ⚠This panel does not detect all possible genetic causes; some rare genes may not be included.
- ⚠Large deletions/duplications may not be detected by standard NGS; additional testing may be required.
- ⚠Variant of uncertain significance (VUS) may be reported; further family studies may be needed.
- ⚠Prenatal samples require prior genetic counseling and appropriate consent.
Risks & Considerations
- ●Blood draw: minimal risk of bruising or infection
- ●Amniocentesis/CVS: small risk of miscarriage or infection (performed by specialist)
- ●Psychological impact of genetic results
Interfering Factors
- ●Poor DNA quality or quantity from sample
- ●Contamination of sample
- ●Incomplete clinical information
- ●Genetic variants in non-coding regions not covered by NGS
Compare With Similar Tests
| Test | Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel | Whole Exome Sequencing | Targeted Single Gene Testing |
|---|---|---|---|
| Comparison | Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel |
Frequently Asked Questions
What is the cost of the Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel?
What sample types are accepted for this test?
Is fasting required before the test?
How long does it take to get the results?
Do I need a doctor's prescription for this test?
Can this test be done during pregnancy?
What genes are included in this panel?
What does a positive result mean?
What if no pathogenic variant is found?
Is home sample collection available?
Are there any risks associated with prenatal sample collection?
How can I book this test?
Related Tests
Angelman Syndrome Test
₹10,000Duchenne / Becker Muscular Dystrophy (DMD / BMD) Gene Mutation Test
₹14,000Episodic Ataxia Type 1 Hotspot Test
₹11,500Episodic Ataxia Comprehensive Profile Hotspot Test
₹16,000Megalencephalic Leukoencephalopathy with Subcortical Cysts Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test
₹7,500Analyzer 18 SMA 18 Test Panel
₹1,755Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.
